Publications
Showing all 96 journal articles & 0 books available
Journal Articles
12/2014
Corsetti JP, Gansevoort RT, Bakker SJ, Sparks CE, Vart P, Dullaart RP. "Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants." Journal of the American Society of Nephrology : JASN.. 2014 Dec; 25(12):2906-15. Epub 2014 May 22.
6/2014
Sparks CE, Corsetti JP, Sparks JD. "High-density lipoproteins: taking the good with the bad." Current opinion in lipidology.. 2014 Jun; 25(3):230-2.
10/2013
Sparks CE, Sparks JD. "Hepatic postprandial transition and very low-density lipoprotein biogenesis." Current opinion in lipidology.. 2013 Oct; 24(5):450-2.
2013
Corsetti JP, Salzman P, Ryan D, Moss AJ, Zareba W, Sparks CE. "Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels." PloS one.. 2013 8(7):e68920. Epub 2013 Jul 09.
9/2012
Sparks JD, Sparks CE, Adeli K. "Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia." Arteriosclerosis, thrombosis, and vascular biology.. 2012 Sep; 32(9):2104-12. Epub 2012 Jul 12.
8/2012
Sparks CE, Sparks JD. "Hepatic steatosis and VLDL hypersecretion." Current opinion in lipidology.. 2012 Aug; 23(4):395-7.
7/2012
Corsetti JP, Gansevoort RT, Bakker SJ, Navis G, Sparks CE, Dullaart RP. "Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein." Metabolism: clinical and experimental.. 2012 Jul; 61(7):996-1002. Epub 2012 Jan 05.
3/11/2011
Sparks JD, Chamberlain J, O'Dell C, Khatun I, Hussain MM, Sparks CE. "Acute suppression of apo B secretion by insulin occurs independently of MTP." Biochemical and biophysical research communications.. 2011 Mar 11; 406(2):252-6. Epub 2011 Feb 18.
10/2010
Sparks JD, Cianci J, Jokinen J, Chen LS, Sparks CE. "Interleukin-6 mediates hepatic hypersecretion of apolipoprotein B." American journal of physiology. Gastrointestinal and liver physiology.. 2010 Oct; 299(4):G980-9. Epub 2010 Jul 22.
8/2010
Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Sparks CE. "Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels." Arteriosclerosis, thrombosis, and vascular biology.. 2010 Aug; 30(8):1657-64. Epub 2010 May 20.
6/2010
Corsetti JP, Gansevoort RT, Sparks CE, Dullaart RP. "Inflammation reduces HDL protection against primary cardiac risk." European journal of clinical investigation.. 2010 Jun; 40(6):483-9. Epub 2010 Apr 14.
6/2010
Sparks CE, Sparks JD. "Lipid metabolism: insights into the complexity of VLDL metabolic pathways." Current opinion in lipidology.. 2010 Jun; 21(3):280-1.
12/2008
Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Block RC, Sparks CE. "Lp(a) and risk of recurrent cardiac events in obese postinfarction patients." Obesity.. 2008 Dec; 16(12):2717-22. Epub 2008 Oct 16.
6/2008
Sparks JD, Sparks CE. "Overindulgence and metabolic syndrome: is FoxO1 a missing link?" The Journal of clinical investigation.. 2008 Jun; 118(6):2012-5.
3/2008
Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, Sparks CE. "Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients." Arteriosclerosis, thrombosis, and vascular biology.. 2008 Mar; 28(3):548-54. Epub 2007 Dec 20.
1/2008
Corsetti JP, Ryan D, Moss AJ, Zareba W, Sparks CE. "NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients." Atherosclerosis.. 2008 Jan; 196(1):461-8. Epub 2007 Jan 09.
2008
Corsetti, J.P.; Ryan, D.; Moss, A.J.; Rainwater, D.L.; Zareba, W.; Sparks, C.E.;. "Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients" . Arterioscler Thromb Vasc Biol. 2008; 28(3): 548-54.
2008
Sparks, J.D.; Sparks, C.E.;. "Overindulgence and metabolic syndrome: is FoxO1 a missing link?" . J Clin Invest. 2008; 118(6): 2012-5.
5/2007
Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, Sparks CE. "Glycoprotein Ibalpha polymorphism T145M, elevated lipoprotein-associated phospholipase A2, and hypertriglyceridemia predict risk for recurrent coronary events in diabetic postinfarction patients." Diabetes.. 2007 May; 56(5):1429-35. Epub 2007 Feb 15.
9/2006
Chirieac DV, Davidson NO, Sparks CE, Sparks JD. "PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice." American journal of physiology. Gastrointestinal and liver physiology.. 2006 Sep; 291(3):G382-8. Epub 2006 Jun 22.
7/2006
Corsetti JP, Zareba W, Moss AJ, Rainwater DL, Sparks CE. "Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation." Atherosclerosis.. 2006 Jul; 187(1):191-7. Epub 2005 Oct 20.
7/2006
Corsetti JP, Rainwater DL, Moss AJ, Zareba W, Sparks CE. "High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients." Clinical chemistry.. 2006 Jul; 52(7):1331-8. Epub 2006 May 18.
4/15/2006
Sparks JD, Collins HL, Chirieac DV, Cianci J, Jokinen J, Sowden MP, Galloway CA, Sparks CE. "Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase." The Biochemical journal.. 2006 Apr 15; 395(2):363-71.
12/2005
Corsetti JP, Zareba W, Moss AJ, Sparks CE. "Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patients." Atherosclerosis.. 2005 Dec; 183(2):293-300. Epub 2005 May 31.
7/15/2005
Moss AJ, Ryan D, Oakes D, Goldstein RE, Greenberg H, Bodenheimer MM, Brown MW, Case RB, Dwyer EM, Eberly SW, Francis CW, Gillespie JA, Krone RJ, Lichstein E, MacCluer JW, Marcus FI, McCarthy J, Sparks CE, Zareba W. "Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction." The American journal of cardiology.. 2005 Jul 15; 96(2):177-82.
12/2004
Corsetti JP, Zareba W, Moss AJ, Sparks CE. "Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome." Atherosclerosis.. 2004 Dec; 177(2):367-73.
7/2004
Chirieac DV, Collins HL, Cianci J, Sparks JD, Sparks CE. "Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats." American journal of physiology. Endocrinology and metabolism.. 2004 Jul; 287(1):E42-9. Epub 2004 Feb 17.
12/2003
Corsetti JP, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rainwater DL, Sparks CE. "Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients." Atherosclerosis.. 2003 Dec; 171(2):351-8.
4/2003
Fadl YY, Zareba W, Moss AJ, Marder VJ, Sparks CS, Miller Watelet LF, Carroll ER. "History of hypertension and enhanced thrombogenic activity in postinfarction patients." Hypertension.. 2003 Apr; 41(4):943-9. Epub 2003 Mar 10.
9/13/2002
Chirieac DV, Cianci J, Collins HL, Sparks JD, Sparks CE. "Insulin suppression of VLDL apo B secretion is not mediated by the LDL receptor." Biochemical and biophysical research communications.. 2002 Sep 13; 297(1):134-7.
1/15/2002
Harb TS, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rifai N, Miller Watelet LF, Arora R, Brown MW, Case RB, Dwyer EM, Gillespie JA, Goldstein RE, Greenberg H, Hochman J, Krone RJ, Liang CS, Lichstein E, Little W, Marcus FI, Oakes D, Sparks CE, VanVoorhees L, . "Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction." The American journal of cardiology.. 2002 Jan 15; 89(2):216-21.
9/2001
Zareba W, Pancio G, Moss AJ, Kalaria VG, Marder VJ, Weiss HJ, Watelet LF, Sparks CE. "Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators." Thrombosis and haemostasis.. 2001 Sep; 86(3):791-9.
11/2000
Chirieac DV, Chirieac LR, Corsetti JP, Cianci J, Sparks CE, Sparks JD. "Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production." American journal of physiology. Endocrinology and metabolism.. 2000 Nov; 279(5):E1003-11.
11/2000
Sparks JD, Shaw WN, Corsetti JP, Bolognino M, Pesek JF, Sparks CE. "Insulin-treated Zucker diabetic fatty rats retain the hypertriglyceridemia associated with obesity." Metabolism: clinical and experimental.. 2000 Nov; 49(11):1424-30.
10/15/2000
Fisher SD, Zareba W, Moss AJ, Marder VJ, Sparks CE, Hochman J, Liang C, Krone RJ, . "Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction." The American journal of cardiology.. 2000 Oct 15; 86(8):813-8.
7/14/2000
Collins HL, Sparks CE, Sparks JD. "B48 is preferentially translated over B100 in cells with increased endogenous apo B mRNA." Biochemical and biophysical research communications.. 2000 Jul 14; 273(3):1156-60.
6/15/2000
Kalaria VG, Zareba W, Moss AJ, Pancio G, Marder VJ, Morrissey JH, Weiss HJ, Sparks CE, Greenberg H, Dwyer E, Goldstein R, Watelet LF. "Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators." The American journal of cardiology.. 2000 Jun 15; 85(12):1401-8.
2/2000
Corsetti JP, Sparks JD, Peterson RG, Smith RL, Sparks CE. "Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats." Atherosclerosis.. 2000 Feb; 148(2):231-41.
8/1/1999
Sowden MP, Collins HL, Smith HC, Garrow TA, Sparks JD, Sparks CE. "Apolipoprotein B mRNA and lipoprotein secretion are increased in McArdle RH-7777 cells by expression of betaine-homocysteine S-methyltransferase." The Biochemical journal.. 1999 Aug 1; 341 ( Pt 3):639-45.
5/18/1999
Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, Van Voorhees L, Krone RJ, Bodenheimer MM, Hochman J, Dwyer EM, Arora R, Marcus FI, Watelet LF, Case RB. "Thrombogenic factors and recurrent coronary events." Circulation.. 1999 May 18; 99(19):2517-22.
11/18/1998
Van Mater D, Sowden MP, Cianci J, Sparks JD, Sparks CE, Ballatori N, Smith HC. "Ethanol increases apolipoprotein B mRNA editing in rat primary hepatocytes and McArdle cells." Biochemical and biophysical research communications.. 1998 Nov 18; 252(2):334-9.
11/1998
Sparks JD, Phung TL, Bolognino M, Cianci J, Khurana R, Peterson RG, Sowden MP, Corsetti JP, Sparks CE. "Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia." Metabolism: clinical and experimental.. 1998 Nov; 47(11):1315-24.
3/1998
Moyer MP, Tracy RP, Tracy PB, van't Veer C, Sparks CE, Mann KG. "Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes." Arteriosclerosis, thrombosis, and vascular biology.. 1998 Mar; 18(3):458-65.
12/5/1997
Phung TL, Roncone A, Jensen KL, Sparks CE, Sparks JD. "Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum." The Journal of biological chemistry.. 1997 Dec 5; 272(49):30693-702.
8/18/1997
Phung TL, Mooney RA, Kulas DT, Sparks CE, Sparks JD. "Suppression of the protein tyrosine phosphatase LAR reduces apolipoprotein B secretion by McA-RH7777 rat hepatoma cells." Biochemical and biophysical research communications.. 1997 Aug 18; 237(2):367-71.
7/12/1997
Sparks JD, Collins HL, Sabio I, Sowden MP, Smith HC, Cianci J, Sparks CE. "Effects of fatty acids on apolipoprotein B secretion by McArdle RH-7777 rat hepatoma cells." Biochimica et biophysica acta.. 1997 Jul 12; 1347(1):51-61.
9/1996
Phung TL, Sowden MP, Sparks JD, Sparks CE, Smith HC. "Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat." Metabolism: clinical and experimental.. 1996 Sep; 45(9):1056-8.
2/6/1996
Schock D, Kuo SR, Steinburg MF, Bolognino M, Sparks JD, Sparks CE, Smith HC. "An auxiliary factor containing a 240-kDa protein complex is involved in apolipoprotein B RNA editing." Proceedings of the National Academy of Sciences of the United States of America.. 1996 Feb 6; 93(3):1097-102.
1/15/1996
Sparks JD, Phung TL, Bolognino M, Sparks CE. "Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes." The Biochemical journal.. 1996 Jan 15; 313 ( Pt 2):567-74.
1996
Sparks JD, Sparks CE. "Chromatographic method for isolation and quantification of apolipoproteins B-100 and B-48." Methods in enzymology.. 1996 263:104-20.
11/30/1994
Sparks JD, Sparks CE. "Obese Zucker (fa/fa) rats are resistant to insulin's inhibitory effect on hepatic apo B secretion." Biochemical and biophysical research communications.. 1994 Nov 30; 205(1):417-22.
11/17/1994
Sparks JD, Sparks CE. "Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion." Biochimica et biophysica acta.. 1994 Nov 17; 1215(1-2):9-32.
6/1994
Sparks JD, Corsetti JP, Sparks CE. "Liver regrowth and apolipoprotein B secretion by rat hepatocytes following partial hepatectomy." Metabolism: clinical and experimental.. 1994 Jun; 43(6):681-90.
2/1994
Björnsson OG, Sparks JD, Sparks CE, Gibbons GF. "Regulation of VLDL secretion in primary culture of rat hepatocytes: involvement of cAMP and cAMP-dependent protein kinases." European journal of clinical investigation.. 1994 Feb; 24(2):137-48.
4/5/1993
Harris SG, Sabio I, Mayer E, Steinberg MF, Backus JW, Sparks JD, Sparks CE, Smith HC. "Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins." The Journal of biological chemistry.. 1993 Apr 5; 268(10):7382-92.
4/1993
Corsetti JP, Sparks JD, Sikora B, Sparks CE. "Cellular heterogeneity in binding and uptake of low-density lipoprotein in primary rat hepatocytes." Hepatology : official journal of the American Association for the Study of Liver Diseases.. 1993 Apr; 17(4):645-50.
11/1/1992
Gibbons GF, Bartlett SM, Sparks CE, Sparks JD. "Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes." The Biochemical journal.. 1992 Nov 1; 287 ( Pt 3):749-53.
7/1992
Björnsson OG, Sparks JD, Sparks CE, Gibbons GF. "Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures: relationships to hepatic calcium metabolism." Journal of lipid research.. 1992 Jul; 33(7):1017-27.
6/1992
Corsetti JP, Way BA, Sparks CE, Sparks JD. "Immunolocalization, quantitation and cellular heterogeneity of apolipoprotein B in rat hepatocytes." Hepatology : official journal of the American Association for the Study of Liver Diseases.. 1992 Jun; 15(6):1117-24.
5/1992
Sparks JD, Zolfaghari R, Sparks CE, Smith HC, Fisher EA. "Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats." The Journal of clinical investigation.. 1992 May; 89(5):1418-30.
1/15/1992
Björnsson OG, Duerden JM, Bartlett SM, Sparks JD, Sparks CE, Gibbons GF. "The role of pancreatic hormones in the regulation of lipid storage, oxidation and secretion in primary cultures of rat hepatocytes. Short- and long-term effects." The Biochemical journal.. 1992 Jan 15; 281 ( Pt 2):381-6.
7/1991
Corsetti JP, Sterry JA, Sparks JD, Sparks CE, Weintraub M. "Effect of weight loss on serum lipoprotein(a) concentrations in an obese population." Clinical chemistry.. 1991 Jul; 37(7):1191-5.
5/15/1991
Corsetti JP, Weidner CH, Cianci J, Sparks CE. "The labeling of lipoproteins for studies of cellular binding with a fluorescent lipophilic dye." Analytical biochemistry.. 1991 May 15; 195(1):122-8.
2/15/1991
Smith HC, Kuo SR, Backus JW, Harris SG, Sparks CE, Sparks JD. "In vitro apolipoprotein B mRNA editing: identification of a 27S editing complex." Proceedings of the National Academy of Sciences of the United States of America.. 1991 Feb 15; 88(4):1489-93.
7/31/1990
Backus JW, Eagleton MJ, Harris SG, Sparks CE, Sparks JD, Smith HC. "Quantitation of endogenous liver apolipoprotein B mRNA editing." Biochemical and biophysical research communications.. 1990 Jul 31; 170(2):513-8.
5/25/1990
Sparks JD, Sparks CE. "Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes." The Journal of biological chemistry.. 1990 May 25; 265(15):8854-62.
4/1990
Greenland P, Bowley NL, Meiklejohn B, Doane KL, Sparks CE. "Blood cholesterol concentration: fingerstick plasma vs venous serum sampling." Clinical chemistry.. 1990 Apr; 36(4):628-30.
2/1990
Greenland P, Bowley NL, French CA, Meiklejohn B, Gagliano S, Sparks CE. "Precision and accuracy of a portable blood analyzer system during cholesterol screening." American journal of public health.. 1990 Feb; 80(2):181-4.
10/15/1989
Kwong TC, Sparks JD, Pryce DJ, Cianci JF, Sparks CE. "Inhibition of apolipoprotein B net synthesis and secretion from cultured rat hepatocytes by the calcium-channel blocker diltiazem." The Biochemical journal.. 1989 Oct 15; 263(2):411-5.
7/1/1989
Sparks JD, Sparks CE, Miller LL. "Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes." The Biochemical journal.. 1989 Jul 1; 261(1):83-8.
9/1988
Jackson TK, Salhanick AI, Sparks JD, Sparks CE, Bolognino M, Amatruda JM. "Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes." Diabetes.. 1988 Sep; 37(9):1234-40.
7/1988
Sparks JD, Sparks CE, Bolognino M, Roncone AM, Jackson TK, Amatruda JM. "Effects of nonketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes." The Journal of clinical investigation.. 1988 Jul; 82(1):37-43.
4/15/1988
Sparks JD, Sparks CE, Roncone AM, Amatruda JM. "Secretion of high and low molecular weight phosphorylated apolipoprotein B by hepatocytes from control and diabetic rats. Phosphorylation of APO BH and APO BL." The Journal of biological chemistry.. 1988 Apr 15; 263(11):5001-4.
9/1987
Tetrault GA, Meiklejohn BA, Sparks CE. "Clinical utility of Ektachem-determined bilirubin fractions for classifying adult inpatients." Clinical chemistry.. 1987 Sep; 33(9):1662-4.
12/1986
Sparks CE, Sparks JD, Bolognino M, Salhanick A, Strumph PS, Amatruda JM. "Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes." Metabolism: clinical and experimental.. 1986 Dec; 35(12):1128-36.
9/1986
Sparks JD, Bolognino M, Trax PA, Sparks CE. "The production and utility of monoclonal antibodies to rat apolipoprotein B lipoproteins." Atherosclerosis.. 1986 Sep; 61(3):205-11.
5/1986
Sparks JD, Sparks CE, Kritchevsky D. "Hypercholesterolemia and aortic glycosaminoglycans of rabbits fed semi-purified diets containing sucrose and lactose." Atherosclerosis.. 1986 May; 60(2):183-96.
3/1986
Shah NM, Eskin BA, Krouse TB, Sparks CE. "Iodoprotein formation by rat mammary glands during pregnancy and early postpartum period." Proceedings of the Society for Experimental Biology and Medicine.. 1986 Mar; 181(3):443-9.
2/1985
Kwong TC, Sparks JD, Sparks CE. "Lipoprotein and protein binding of the calcium channel blocker diltiazem." Proceedings of the Society for Experimental Biology and Medicine.. 1985 Feb; 178(2):313-6.
1985
Sparks JD, Sparks CE. "Apolipoprotein B and lipoprotein metabolism." Advances in lipid research. 1985 21:1-46.
10/1984
Garber DW, Gottlieb BA, Marsh JB, Sparks CE. "Catabolism of very low density lipoproteins in experimental nephrosis." The Journal of clinical investigation.. 1984 Oct; 74(4):1375-83.
5/16/1983
Krebs KE, Phillips MC, Sparks CE. "A comparison of the surface activities of rat plasma apolipoproteins C-II, C-III-0, C-III-3." Biochimica et biophysica acta.. 1983 May 16; 751(3):470-3.
2/1983
Sparks CE, Rader DJ, Marsh JB. "Metabolism of two forms of apolipoprotein B of VLDL by rat liver." Journal of lipid research.. 1983 Feb; 24(2):156-66.
6/1982
Marsh JB, Sparks CE. "The effect of fasting on the secretion of lipoproteins and two forms of apo B by perfused rat liver." Proceedings of the Society for Experimental Biology and Medicine.. 1982 Jun; 170(2):178-81.
11/23/1981
Rash JM, Rothblat GH, Sparks CE. "Lipoprotein apolipoprotein synthesis by human hepatoma cells in culture." Biochimica et biophysica acta.. 1981 Nov 23; 666(2):294-8.
8/1981
Sparks CE, Hnatiuk O, Marsh JB. "Hepatic and intestinal contribution of two forms of apolipoprotein B to plasma lipoprotein fractions in the rat." Canadian journal of biochemistry.. 1981 Aug; 59(8):693-9.
7/24/1981
Sparks CE, Tennenberg SD, Marsh JB. "Catabolism of the apolipoproteins of HDL in control and nephrotic rats." Biochimica et biophysica acta.. 1981 Jul 24; 665(1):8-12.
4/1981
Sparks CE, Tennenberg SD, Marsh JB. "Catabolism of apoprotein A-1 of HDL in normal and nephrotic rats." Metabolism: clinical and experimental.. 1981 Apr; 30(4):354-8.
3/1981
Sparks CE, Marsh JB. "Analysis of lipoprotein apoproteins by SDS-gel filtration column chromatography." Journal of lipid research.. 1981 Mar; 22(3):514-8.
3/1981
Sparks CE, Marsh JB. "Metabolic heterogeneity of apolipoprotein B in the rat." Journal of lipid research.. 1981 Mar; 22(3):519-27.
11/1979
Marsh JB, Sparks CE. "Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis." The Journal of clinical investigation.. 1979 Nov; 64(5):1229-37.
10/1979
Marsh JB, Sparks CE. "Lipoproteins in experimental nephrosis: plasma levels and composition." Metabolism: clinical and experimental.. 1979 Oct; 28(10):1040-5.
9/27/1979
Capuzzi DM, Sparks CE, DeHoff JL. "Effect of residual enzymes on degradation of radioiodinated VLDL by collagenase-dispersed hepatocytes." Biochemical and biophysical research communications.. 1979 Sep 27; 90(2):587-95.
4/28/1978
Sparks CE, Dehoff JL, Capuzzi DM, Pietra G, Marsh JB. "Proteolysis of very low density lipoprotein in perfused lung." Biochimica et biophysica acta.. 1978 Apr 28; 529(1):123-30.
7/1976
Pietra GG, Spagnoli LG, Capuzzi DM, Sparks CE, Fishman AP, Marsh JB. "Metabolism of 125I-labeled lipoproteins by the isolated rat lung." The Journal of cell biology.. 1976 Jul; 70(1):33-46.
12/1963
BAGLIONI C, SPARKS CE. "A STUDY OF HEMOGLOBIN DIFFERENTIATION IN RANA CATESBEIANA." Developmental biology.. 1963 Dec; 8:272-85.